Corcept Therapeutics | Dochód Netto



Net Income Zmiana Data
Acadia Pharmaceuticals USD 143.74M 110.98M 2024-12
Alaunos Therapeutics USD -742000 385K 2024-12
ANI Pharmaceuticals USD -10276000 13.89M 2024-12
Ardelyx USD 4.64M 5.45M 2024-12
Aurora Cannabis CAD 31.67M 43.71M 2024-12
BioMarin Pharmaceutical USD 124.94M 18.86M 2024-12
Bristol-Myers Squibb USD 2.46B 2.38B 2025-03
Canopy Growth CAD -121896000 6.4M 2024-12
Corcept Therapeutics USD 30.75M 16.47M 2024-12
Eli Lilly USD 2.76B 1.65B 2025-03
J&J USD 11B 7.57B 2025-03
Knight Therapeutics CAD 85K 2.03M 2024-09
Merck USD 5.08B 1.34B 2025-03
Novartis USD 2.82B 371M 2024-12
Novartis USD 2.82B 371M 2024-12
Pacira USD 16.04M 159.51M 2024-12
Pfizer USD 2.97B 2.56B 2025-03
Supernus Pharmaceuticals USD 15.33M 23.17M 2024-12
TG Therapeutics USD 23.33M 19.45M 2024-12



Corcept Therapeutics Dochód Netto - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - May 2025.